MIOSTAT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Miostat, and when can generic versions of Miostat launch?
Miostat is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in MIOSTAT is carbachol. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the carbachol profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MIOSTAT?
- What are the global sales for MIOSTAT?
- What is Average Wholesale Price for MIOSTAT?
Summary for MIOSTAT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 62 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,524 |
| Drug Prices: | Drug price information for MIOSTAT |
| What excipients (inactive ingredients) are in MIOSTAT? | MIOSTAT excipients list |
| DailyMed Link: | MIOSTAT at DailyMed |
Recent Clinical Trials for MIOSTAT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cairo University | N/A |
Pharmacology for MIOSTAT
| Drug Class | Cholinergic Receptor Agonist |
| Mechanism of Action | Cholinergic Agonists |
US Patents and Regulatory Information for MIOSTAT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon | MIOSTAT | carbachol | SOLUTION;INTRAOCULAR | 016968-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
